Orion completes acquisition of LegoChem Biosciences -
| 141080 Stock | KRW 110,000 1,800 1.61% |
About 62% of LegoChem Biosciences' investor base is looking to short. The analysis of current outlook of investing in LegoChem Biosciences suggests that many traders are alarmed regarding LegoChem Biosciences' prospects. The current market sentiment, together with LegoChem Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use LegoChem Biosciences stock news signals to limit their universe of possible portfolio assets.
LegoChem |
Orion completes acquisition of LegoChem Biosciences
Read at news.google.com
 |
LegoChem Biosciences Fundamental Analysis
We analyze LegoChem Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LegoChem Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LegoChem Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
LegoChem Biosciences is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
LegoChem Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LegoChem Biosciences stock to make a market-neutral strategy. Peer analysis of LegoChem Biosciences could also be used in its relative valuation, which is a method of valuing LegoChem Biosciences by comparing valuation metrics with similar companies.
Peers
LegoChem Biosciences Related Equities
| 248170 | Sempio Foods | 0.56 |
| ||
| 002810 | Samyung Trading | 0.67 |
| ||
| 078020 | EBEST Investment | 1.12 |
| ||
| 003690 | Korean Reinsurance | 1.83 |
| ||
| 101530 | Haitai Confectionery | 1.94 |
| ||
| 005830 | Dongbu Insurance | 2.25 |
| ||
| 016610 | DB Financial | 3.13 |
|
Complementary Tools for LegoChem Stock analysis
When running LegoChem Biosciences' price analysis, check to measure LegoChem Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LegoChem Biosciences is operating at the current time. Most of LegoChem Biosciences' value examination focuses on studying past and present price action to predict the probability of LegoChem Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LegoChem Biosciences' price. Additionally, you may evaluate how the addition of LegoChem Biosciences to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |